Norepinephrine Bitartrate Injection, Solution, Concentrate
Product Images NDC 72572-481

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Norepinephrine Bitartrate (NDC 72572-481). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Civica, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Norepinephrine Civica 01)

FDA Label Image

Carton (Norepinephrine Civica 02)

Carton (Norepinephrine Civica 02)
Norepinephrine Bitartrate Injection, USP is a potent drug that is used only through intravenous infusion. The administered dosage should be regularly controlled by determining blood pressure, and patients should not be left unattended during administration. The medication is provided in 10 single-dose vials of 4 mL each and should be diluted before use. Unused medication should be discarded, and the medication should be protected from light. The package contains Sulftes and its leaflet should be read with care to avoid extravasation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.